Penumbra Interest Expense 2011-2026 | PEN

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Penumbra

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
893 K	-682 K	1.74 M	1.75 M	1.93 M	-343 K	-227 K	-504 K	-1.34 M	-1.84 M	-696 K	-309 K	-474 K	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.93 M	-1.84 M	-8.08 K

Quarterly Interest Expense Penumbra

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-1.1 M	-535 K	812 K	445 K	1.28 M	-226 K	-366 K	-444 K	444 K	416 K	-	-2.36 M	-956 K	-1.01 M	-	-1.14 M	-408 K	-1.48 M	-	14 K	511 K	-1.66 M	-	-772 K	-71 K	24 K	-	170 K	-340 K	-290 K	-	-102 K	-214 K	-349 K	-	-360 K	-272 K	-224 K	-	-115 K	-542 K	44 K	-	-56 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.28 M	-2.36 M	-320 K

Interest Expense of other stocks in the Medical devices industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
Avinger AVGR	1.72 M	-	-20.74 %	$ 369 K	USA
Axonics Modulation Technologies AXNX	624 K	-	-	$ 3.31 B	USA
Eargo EAR	549 K	-	-	$ 10.2 M	USA
Allied Healthcare Products AHPI	191 K	-	3.58 %	$ 2.21 M	USA
ClearPoint Neuro CLPT	-146 K	$ 12.42	1.47 %	$ 352 M	USA
Apollo Endosurgery APEN	4.67 M	-	-	$ 475 M	USA
Alphatec Holdings ATEC	45.9 M	$ 7.87	-0.25 %	$ 1.18 B	USA
Aziyo Biologics AZYO	-2.76 M	-	1.37 %	$ 20.5 M	USA
EDAP TMS S.A. EDAP	232 K	$ 4.38	4.29 %	$ 164 M	France
BioSig Technologies BSGM	1.6 M	-	37.08 %	$ 85.7 M	USA
BIOLASE BIOL	-1 K	-	-13.19 %	$ 166 K	USA
Conformis CFMS	2.02 M	-	-	$ 16.4 M	USA
Cardiovascular Systems CSII	1.63 M	-	0.15 %	$ 844 M	USA
Helius Medical Technologies HSDT	46.9 K	$ 1.91	-6.62 %	$ 42.1 M	USA
OrthoPediatrics Corp. KIDS	6.05 M	$ 17.15	-3.71 %	$ 402 M	USA
LENSAR LNSR	636 K	$ 5.85	-2.5 %	$ 70 M	USA
Delcath Systems DCTH	-70 K	$ 10.9	-0.44 %	$ 390 M	USA
Pulmonx Corporation LUNG	790 K	$ 1.65	-2.08 %	$ 67.1 M	USA
LivaNova PLC LIVN	664 K	$ 73.65	0.84 %	$ 4.02 B	Britain
Myomo MYO	-668 K	$ 1.09	-	$ 45.6 M	USA
Neovasc NVCN	133 K	-	-	$ 111 M	Canada
Dynatronics Corporation DYNT	410 K	-	14.99 %	$ 929 K	USA
MiMedx Group MDXG	-558 K	$ 3.72	1.36 %	$ 550 M	USA
Electromed ELMD	455 K	$ 38.47	-2.09 %	$ 325 M	USA
Orthofix Medical OFIX	8.11 M	$ 9.37	-1.26 %	$ 371 M	Curacao
Butterfly Network BFLY	2.77 M	$ 4.45	-3.58 %	$ 1.1 B	USA
Second Sight Medical Products EYES	947 K	-	-0.97 %	$ 54.4 M	USA
Profound Medical Corp. PROF	146 K	$ 6.85	-0.8 %	$ 207 M	Canada
Globus Medical GMED	3.41 M	$ 81.72	-0.9 %	$ 11 B	USA
Insulet Corporation PODD	14.3 M	$ 142.42	-0.16 %	$ 10 B	USA
Sintx Technologies SINT	31 K	$ 2.23	1.14 %	$ 6.18 M	USA
CONMED Corporation CNMD	31.1 M	$ 35.7	0.79 %	$ 1.11 B	USA
Inspire Medical Systems INSP	-2.66 M	$ 42.07	-2.39 %	$ 1.24 B	USA
Integer Holdings Corporation ITGR	-53.2 M	$ 90.31	0.31 %	$ 3.14 B	USA
Invacare Corporation IVC	28.5 M	-	-	$ 24.7 M	USA
Edwards Lifesciences Corporation EW	7.2 M	$ 86.15	0.23 %	$ 50.4 B	USA
TransMedics Group TMDX	3.87 M	$ 67.33	-0.73 %	$ 2.29 B	USA